Methylprednisolone Sodium Succinate Injection
Product Images NDC 43598-129

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Methylprednisolone Sodium Succinate (NDC 43598-129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

FDA Label Image

Carton2 (Carton2)

Carton2 (Carton2)
This is a description of a medication called methylPREDNISolone Sodium Succinate for Injection. Each vial contains 125 mg of the medication. No further information is available.*
FDA Label Image

Carton3 (Carton3)

FDA Label Image

Carton4 (Carton4)

FDA Label Image

Container1 (Container1)

Container1 (Container1)
This is a medication with National Drug Code 43598-127-45. It needs to be reconstituted with either 1 mL of Water for Injection or Bacteriostatic Water for Injection with Benzyl Alcohol. Each mL (when reconstituted) contains Sodium Succinate methylprednisolone sodium succinate equivalent to methylprednisolone, 40 mg. It is used for injection and is for intramuscular or intravenous use only. It is lyophilized in the container and should be protected from light. The medication is manufactured by Tianjin Kingyork Pharmaceuticals Co., Ltd. in China and distributed by Dr. Reddy’s Laboratories, Inc. in Princeton, NJ, USA. The dosage information is available in the accompanying prescribing information.*
FDA Label Image

Container2 (Container2)

Container2 (Container2)
This is a medication with National Drug Code 43598-129-01 that needs to be reconstituted with 2mL water for injection or bacteriostatic water for injection before use. The medication contains methylprednisolone and sodium succinate, equivalent to 125 mg of methylprednisolone when reconstituted. It is for intramuscular or intravenous use only and should be protected from light. The medication is distributed by Dr. Reddy's Laboratories and manufactured by Tianjin Kingyork Pharmaceuticals in China. The recommended dosage information is included in the prescribing information. Unused portions should be discarded.*
FDA Label Image

Container3 (Container3)

Container3 (Container3)
This is a package of Methyprednisolone, a drug that is available in a vial of 500 mg, but the package does not contain the recommended diluent. The instructions state to use 8mL of bacteriostatic water for injection to reconstitute the solution, after which it will be 62.5mg per mL. The reconstituted solution should be stored between 20° to 25°C and used within 48 hours of mixing while protecting it from light. The package is intended for intravenous use and has been manufactured by Tenjin Kingyork Pharmaceuticals CO, Ltd in Tianjin, China. The package has been distributed by Dr. Reddy’s Laboratories in Princeton, NJ.*
FDA Label Image

Container4 (Container4)

Container4 (Container4)
This is a medication called MethylPrednisolone Sodium Succinate, packaged in a multi-dose vial with 1g of the drug per vial. It is intended only for intramuscular or intravenous use and requires a diluent (Bacteriostatic Water for Injection with Benzyl Alcohol) to be mixed before use. Once reconstituted with the proper amount of diluent, it has a concentration of 62.5 mg per mL. The package was manufactured in Tiariin, China, and distributed by Dr. Reddy's Laboratories in USA. Dosage and prescribing information are included but not available in this text.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.